A meta-analysis between schizophrenia patients and healthy controls was performed, with the results suggesting four apolipoproteins, APOA1, APOA2, APOC1 and APOC3 (downregulated), and ficolin-3 (upregulated) as potential biomarkers of the disorder. Here, FCN3 is linked to schizophrenia.